Overview

XOMA’s technology and expertise drive antibody discovery and development across the life science industry.  

Building on our success and utilizing our expertise in therapeutic antibodies, and strong intellectual property position, XOMA has established long-term alliances with leading pharmaceutical and biotechnology companies.  

We maximize the value of our alliances – both product collaborations and technology licensing agreements - to generate revenues that support our goal of creating life-changing therapies.

Our partners include world-class pharmaceutical and biotechnology companies like Novartis AG, Merck & Co. Inc., and Takeda Pharmaceutical Company Limited.  In addition to generating revenue and providing access to our partners’ drug targets, these relationships support ongoing development of our product pipeline.  

XOMA licenses BCE technology to partners including Genentech, Biogen Idec, Eli Lilly and Co., and Pfizer.